Strive Inc.'s stock has declined by 6.30% and is currently trading at $0.96, crossing below its 20-day SMA.
The company recently completed the acquisition of Semler Scientific, which has positioned Strive as the 11th largest public corporate holder of Bitcoin, with approximately 12,797.9 bitcoins. Additionally, Avik Roy has been appointed as Chief Strategy Officer to enhance the monetization of Semler's early disease detection products, which is expected to drive growth in the healthcare technology sector. Despite these strategic moves, Strive's stock struggles to maintain momentum, trading significantly below its 100-day SMA.
The implications of this acquisition could lead to increased competitiveness in both the cryptocurrency and healthcare markets, but the current stock performance indicates challenges in investor confidence.
Wall Street analysts forecast ASST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASST is 1.50 USD with a low forecast of 1.50 USD and a high forecast of 1.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast ASST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASST is 1.50 USD with a low forecast of 1.50 USD and a high forecast of 1.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.786
Low
1.50
Averages
1.50
High
1.50
Current: 0.786
Low
1.50
Averages
1.50
High
1.50
Maxim
Buy
initiated
$1.50
2025-12-10
Reason
Maxim
Price Target
$1.50
AI Analysis
2025-12-10
initiated
Buy
Reason
Maxim initiated coverage of Strive with a Buy rating and $1.50 price target. The company stands out in the digital-asset treasury space with scale, a clean balance sheet, a focus on common and perpetual preferred equity for financing, and deep macro experience, the analyst tells investors in a research note. Maxim adds that it expects rapid scaling of BTC assets as capital markets activity expands the balance sheet.
Benchmark
Buy
downgrade
$101 -> $86
2025-09-23
Reason
Benchmark
Price Target
$101 -> $86
2025-09-23
downgrade
Buy
Reason
Benchmark lowered the firm's price target on Semler Scientific (SMLR) to $86 from $101 and keeps a Buy rating on the shares after Semler agreed to be acquired by Strive (ASST) in an all-stock deal. While the market is sorting out the longer-term implications of the transaction, it appears to the firm that Semler shares \"represent an opportunity right now\" and that this deal seems to have \"rung the opening bell for consolidation in the corporate bitcoin treasury space,\" the analyst tells investors.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for ASST
Unlock Now
About ASST
Strive, Inc., formerly Asset Entities Inc., is an asset management Bitcoin treasury company. The Company is focused on increasing Bitcoin per share to outperform Bitcoin over the long run. The Company's subsidiary, Strive Asset Management, LLC, is an SEC-registered investment adviser, which has assets under management (AUM) across approximately 13 exchange-traded funds, collective investment trusts, and a direct indexing platform.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
